Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations

Table 2

Cutaneous melanoma patients’ characteristics at presentation, percentage of patients diagnosed in different stages, age, and gender.

Stage at presentation; (% out of the total group)	I; (34%)	II; (40%)	III; (15%)	IV; (11%)
Age (mean ± SD years)	57 ± 3	51 ± 4	59 ± 1	67 ± 4
Age range (years)	18–72	20–68	22–89	35–70
Gender (% women)	89%	72%	33%	66%